| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8777216 | The Breast | 2016 | 5 Pages |
Abstract
We identified substantial variation in the use of G-CSF within the practice. However, omission of G-CSF was not associated with treatment delays or adverse events. Prospective studies are warranted to formally test whether routine G-CSF is necessary during dose-dense T therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Romualdo Barroso-Sousa, Flavia Rocha Paes, Ines Vaz-Luis, Rafael Borges Batista, Rafael Brant Costa, Katya Losk, Kristen Camuso, Otto Metzger-Filho, Melissa E. Hughes, Craig A. Bunnell, Mehra Golshan, Eric P. Winer, Nancy U. Lin,